Related Experiment Videos
[Angio-immunoblastic lymphadenopathy (author's transl)].
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|April 8, 1980
Summary
Angio-immunoblastic lymphadenopathy (AILD) presents with constant adenopathy, fever, and weight loss. Despite potential remissions, AILD has a severe prognosis due to frequent infections and risk of transformation into immunoblastic sarcoma.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- Review of literature since 1972 on angio-immunoblastic lymphadenopathy (AILD).
- Focus on defining key clinical, biological, and prognostic features of AILD.
- Established Flandrin's initial description as a historical marker.
Purpose:
- To consolidate current understanding of AILD's presentation and progression.
- To highlight diagnostic markers and clinical course.
- To inform clinical management and research directions.
Summary:
- Clinically, AILD is characterized by persistent adenopathy, fever, weight loss, and often hepatosplenomegaly.
- Biological hallmarks include hemolytic anemia and polyclonal hyperglobulinemia, indicative of immune dysregulation.
- Prognosis remains severe, with high risks of fatal infections and transformation to immunoblastic sarcoma.
Impact:
- Provides a comprehensive overview for clinicians and researchers.
- Emphasizes the diagnostic and prognostic challenges posed by AILD.
- Underscores the need for improved therapeutic strategies against this aggressive lymphoma.